TrialPath
Recruiting

Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed Hypertension

NCT07728630 · Josip Juraj Strossmayer University of Osijek
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Endothelial Extracellular Vesicles as Biomarkers of Blood Pressure-Induced Endothelial Activation in Adults With Newly Diagnosed Untreated Hypertension
About this study
Hypertension is associated with endothelial dysfunction, an early event in the development of cardiovascular disease. Endothelial extracellular vesicles (EEVs) have emerged as promising biomarkers of endothelial activation and vascular injury; however, their relationship with blood pressure and microvascular endothelial function in untreated hypertension remains insufficiently understood. This observational case-control study aims to compare circulating EEV concentrations between normotensive adults and adults with newly diagnosed, untreated primary hypertension. In addition, the study will investigate the associations between EEV levels, blood pressure, microvascular endothelial function assessed by laser Doppler flowmetry, and established circulating biomarkers of endothelial activation. The findings may improve understanding of the role of EEVs in early hypertension and support their potential use as non-invasive biomarkers of endothelial dysfunction and cardiovascular risk.
Eligibility criteria
Inclusion Criteria: * Adults aged 18 years or older. * Ability and willingness to provide written informed consent. * Normotensive individuals or individuals with newly diagnosed, previously untreated primary hypertension, classified according to the European Society of Hypertension (ESH) guidelines. * Ability to comply with all study procedures. Exclusion Criteria: * Secondary hypertension. * Previous treatment with antihypertensive medication. * History of cardiovascular disease (except newly diagnosed primary hypertension in the hypertensive group). * Diabetes mellitus. * Chronic kidney disease. * Cerebrovascular disease. * Peripheral arterial disease. * Acute or chronic inflammatory or infectious disease. * Active malignancy. * Pregnancy or breastfeeding. * Current use of oral contraceptives, hormone replacement therapy, or medications known to affect endothelial function. * Inability or unwillingness to provide informed consent.
Study design
Enrollment target: 80 participants
Age groups: adult, older_adult
Timeline
Starts: 2026-05-01
Estimated completion: 2029-09-30
Last updated: 2026-07-27
Primary outcomes
  • • Plasma endothelial extracellular vesicle concentration (Baseline)
Sponsor
Josip Juraj Strossmayer University of Osijek · other
With: Osijek University Hospital
Contacts & investigators
ContactAna Stupin, MD, PhD · contact · ana.stupin@mefos.hr · +38531512800
ContactIvana Jukić, MD, PhD · contact · ivana.jukic@mefos.hr
InvestigatorAna Stupin, MD, PhD · study_chair, Faculty of Medicine Osijek, Josip Juraj Strossmayer of Osijek
All locations (1)
Faculty of Medicine OsijekRecruiting
Osijek, Croatia
Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed Hypertension · TrialPath